MENU
ANRO
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION

Alto Neuroscience (ANRO) Earnings Date & Reports

Alto Neuroscience Inc is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individuals’ neurobiology to develop personalized and effective treatment options... Show more

A.I. Advisor
published Earnings

ANRO is expected to report earnings to rise 26.92% to -66 cents per share on March 20

Alto Neuroscience ANRO Stock Earnings Reports
Q4'25
Est.
$-0.66
Q3'25
Beat
by $0.12
Q2'25
Missed
by $0.05
Q1'25
Beat
by $0.01
Q4'24
Beat
by $0.03
The last earnings report on November 12 showed earnings per share of -51 cents, beating the estimate of -63 cents. With 121.00K shares outstanding, the current market capitalization sits at 617.60M.
View a ticker or compare two or three
ANRO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ANRO showed earnings on November 12, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
369 South San Antonio Road
Phone
+1 650 200-0412
Employees
63
Web
https://www.altoneuroscience.com